FeesSafety
Pluang+

US 10-year Treasury yield briefly tops 5%, pushing mortgage and loan costs higher amid rising diesel prices.

Market News
14 Sep 2026
New York Post
View Source
Bearish
US 10-year Treasury yield briefly tops 5%, pushing mortgage and loan costs higher amid rising diesel prices.

The US 10-year Treasury yield briefly surged past 5% for the first time since 2023, driven by record-high diesel prices and concerns over inflation linked to the Middle East conflict. This rise in yields is significant as it influences mortgage rates, which are nearing 7%, potentially making home loans more expensive for consumers. The increase also impacts auto loans and the stock market, as higher yields offer safer investment alternatives. Despite Treasury efforts to buy back debt, ongoing geopolitical tensions and inflation risks suggest borrowing costs may remain elevated, with the Federal Reserve expected to raise interest rates further in September to combat inflation.

The US 10-year Treasury yield briefly surged past 5%. For readers following US stocks, here is Pluang's market snapshot as of Sep 15, 2026 01:21 WIB: Of 150 priced US stocks tradable on Pluang, 82 rose and 68 fell. Roblox Corp (RBLX) rose 10.97% to USD 50.49, Coinbase Global (COIN) gained 8.90% to USD 190.85, while Hewlett Packard Enterprise (HPE) dropped 8.67% to USD 56.70.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
46 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App